Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Total Non-Current Liabilities: 2012-2024

Historic Total Non-Current Liabilities for Ironwood Pharmaceuticals (IRWD) over the last 11 years, with Dec 2024 value amounting to -$17.1 million.

  • Ironwood Pharmaceuticals' Total Non-Current Liabilities rose 44.14% to -$22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.2 million, marking a year-over-year increase of 44.14%. This contributed to the annual value of -$17.1 million for FY2024, which is 39.80% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Total Non-Current Liabilities stood at -$17.1 million for FY2024, which was up 39.80% from -$28.4 million recorded in FY2023.
  • In the past 5 years, Ironwood Pharmaceuticals' Total Non-Current Liabilities registered a high of -$1.8 million during FY2020, and its lowest value of -$28.4 million during FY2023.
  • For the 3-year period, Ironwood Pharmaceuticals' Total Non-Current Liabilities averaged around -$18.4 million, with its median value being -$17.1 million (2024).
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Total Non-Current Liabilities crashed by 190.96% in 2023 and then skyrocketed by 39.80% in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Total Non-Current Liabilities (Yearly) stood at -$1.8 million in 2020, then tumbled by 98.58% to -$3.5 million in 2021, then crashed by 178.95% to -$9.8 million in 2022, then crashed by 190.96% to -$28.4 million in 2023, then spiked by 39.80% to -$17.1 million in 2024.